Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4640223
Max Phase: Preclinical
Molecular Formula: C73H85BrN11O16S+
Molecular Weight: 1484.51
Molecule Type: Unknown
Associated Items:
ID: ALA4640223
Max Phase: Preclinical
Molecular Formula: C73H85BrN11O16S+
Molecular Weight: 1484.51
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccc(Br)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCC[N+](C)(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCNC(=S)Nc1ccc(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c(C(=O)O)c1)C(N)=O
Standard InChI: InChI=1S/C73H84BrN11O16S/c1-5-53(78-69(96)57(36-42-16-8-6-9-17-42)82-65(92)44-22-24-45(74)25-23-44)66(93)83-58(37-43-18-10-7-11-19-43)70(97)80-55(21-13-15-35-85(2,3)4)67(94)84-59(41-86)71(98)81-56(32-33-62(89)90)68(95)79-54(64(75)91)20-12-14-34-76-73(102)77-46-26-29-49(52(38-46)72(99)100)63-50-30-27-47(87)39-60(50)101-61-40-48(88)28-31-51(61)63/h6-11,16-19,22-31,38-40,53-59,86H,5,12-15,20-21,32-37,41H2,1-4H3,(H13-,75,76,77,78,79,80,81,82,83,84,87,88,89,90,91,92,93,94,95,96,97,98,99,100,102)/p+1/t53-,54-,55-,56-,57-,58-,59-/m0/s1
Standard InChI Key: JZLPRLQRTFDCLM-MQEJUTFJSA-O
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1484.51 | Molecular Weight (Monoisotopic): 1482.5074 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Milosevich N, McFarlane J, Gignac MC, Li J, Brown TM, Wilson CR, Devorkin L, Croft CS, Hof R, Paci I, Lum JJ, Hof F.. (2020) Pan-specific and partially selective dye-labeled peptidic inhibitors of the polycomb paralog proteins., 28 (1): [PMID:31753799] [10.1016/j.bmc.2019.115176] |
Source(1):